Image: Courtesy UnitedHealth Group

UnitedHealth Group and Modify Healthcare have amended the timing of their $thirteen billion merger arrangement, in accordance to Change’s November three earnings assertion.

On November one, Modify and UnitedHealth agreed not to consummate their merger in advance of February 22, 2022, unless they get penned discover from the Division of Justice prior to the day that the DOJ has shut its investigation. 

The merger is also matter to the probable unavailability of selected asked for info by the DOJ.


The merger would blend Change’s info analytics capabilities with UnitedHealth’s OptumInsight.

The acquisition has obtained pushback from selected groups, like the American Medical center Association, which has mentioned the merger threatens to minimize levels of competition for the sale of health care facts technologies providers to hospitals and other health care providers.

After the DOJ obtained a letter from the AHA, it asked equally Modify and UnitedHealth Group for additional facts.

Both equally Modify and UnitedHealth Group have now accredited considerable compliance with the next ask for for facts, Modify mentioned in its earnings assertion. 

“The events have been doing work cooperatively with the DOJ and will carry on to do so,” the enterprise mentioned.

THE Larger sized Development

On January 5, OptumInsight and Modify Healthcare announced their proposal to blend. 

Under the conditions of the arrangement, UnitedHealth Group, through its wholly-owned subsidiary, would receive all of the excellent shares of Modify Healthcare popular stock for $25.75 per share in funds. 

On March 24, Modify and UnitedHealth Group each individual obtained a ask for for additional facts and documentary resources in link with the DOJ’s overview of the merger.

On August 7, the firms entered into a timing arrangement with the DOJ agreeing not to consummate the merger in advance of 120 times pursuing the day on which equally events accredited considerable compliance with the next ask for by the DOJ.

Twitter: @SusanJMorse
E mail the author: [email protected]